Description/Summary

Supplementary figure for the forthcoming publication entitled “Overlapping roles of NADPH Oxidase 4 (Nox4) for diabetic and gadolinium-based contrast agent-induced systemic fibrosis”. Supplementary Figure 2 demonstrates renal changes induced by gadolinium-based contrast agent treatment and experimental diabetes. Photomicrographs analyzed by a blinded veterinary pathologist.

Publication Date

2021

Document Type

Article

File Format

PDF

Comments

The article associated with this dataset is "Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis" attached at the bottom of the file list.

Bruno F, DeAguero J, Do C, Lee DY, Tan C, Escobar GP, Wagner B. Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis. Am J Physiol Renal Physiol. 2021 Apr 1;320(4):F617-F627. doi: 10.1152/ajprenal.00456.2020. Epub 2021 Feb 22. PMID: 33615889; PMCID: PMC8083972.

Overlapping roles of NADPH oxidase 4 fo...pdf (3041 kB)
Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis

Share

COinS